# Adma Biologics, Inc.: Form 8-K, filed Oct 9, 2024

- Company: [Adma Biologics, Inc.](/companies/adma.md) (CIK 1368514)
- Form: 8-K
- Filed: 2024-10-09
- Accepted by EDGAR: Oct 9, 2024, 17:25 ET
- Period: 2024-10-03
- Accession: 0001140361-24-043222
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124043222/ef20037071_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1368514/000114036124043222/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1368514/000114036124043222/ef20037071_8k.htm

Filed Oct 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-043222. Last ingested by Listed: Nov 6, 2026, 02:03 ET. No prices; not investment advice.